ARCHIVES

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 19 No. 04 | January 22, 1993

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

December 10, 2004

Ohio State Becomes 18th Comprehensive Center; UCLA Needs Only To Overcome “Minor” Problems

April 16, 1976

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Smokers’ Quitlines Work, California Study Finds

October 25, 2002

In Brief: More Than 1,600 Taking First Oncology Nurse Certification Exam; FCC Discussions Planned

April 4, 1986